Search Within

Hematologic Malignancies, Division of

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (661)
  2. Meeting Abstract (617)
  3. Research Letter (37)
  4. Review (13)
  5. Book Section (6)
  6. Correspondence (6)
  7. Guidelines (6)
  8. Conference Paper (3)
  9. Miscellaneous (2)
  10. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1352)
  2. Department of Medicine (1349)
  3. Center for Hematologic Malignancies (943)
  4. GSK Faculty (779)
  5. Human Oncology and Pathogenesis Program (575)
  6. Solid Tumor Oncology Division (552)

More Groups

People
  1. Ahmet Dogan (299)
  2. Maria Arcila (207)
  3. Ross Levine (160)
  4. Michael Berger (155)
  5. Steven Horwitz (145)
  6. Mikhail Roshal (142)

More People

Years
  1. 2025 (37)
  2. 2024 (115)
  3. 2023 (151)
  4. 2022 (136)
  5. 2021 (109)
  6. 2020 (147)

More Years

Publications
  1. Blood (276)
  2. Journal of Clinical Oncology (158)
  3. Clinical Cancer Research (46)
  4. Cancer Research (36)
  5. Laboratory Investigation (33)
  6. Modern Pathology (32)

More Publications

Publishers
  1. American Society of Hematology (307)
  2. American Society of Clinical Oncology (177)
  3. Nature Publishing Group (133)
  4. Elsevier Inc. (123)
  5. American Association for Cancer Research (117)
  6. Wiley Blackwell (44)

More Publishers

Results (1352)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The damage sensory molecule TRPA1 positively regulates endogenous thymic regeneration after damage
    Meeting Abstract

    Argyropoulos, K.; Velardi, E.; Tsai, J.; Lazrak, A.; Jahn, L.; Dudakov, J. A.; van den Brink, M. R. M.
    Blood (2017)

    Fulltext@MSK | Save
  • In vitro, in vivo, and parallel phase I evidence support the safety and activity of duvelisib, a PI3K-δ,γ inhibitor, in combination with romidepsin or bortezomib in relapsed/refractory T-cell lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Koch, R.; Mehta-Shah, N.; Myskowski, P.; Kheterpal, M.; Dogan, A.; Davey, T.; Galasso, N.; Evan, M.; Shah, M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Utility of systemic staging in low grade B-cell lymphomas presenting in the skin
    Meeting Abstract

    Kheterpal, M.; Geller, S.; Dai, J.; Pulitzer, M.; Myskowski, P.; Moskowitz, A. J.; Kim, J.; Hoppe, R. T.; Kim, Y. H.; Horwitz, S. M.
    Blood (2017)

    Fulltext@MSK | Save
  • Nervous system regulates thymic regeneration after immune injuries
    Meeting Abstract

    Malard, F.; Argyropoulos, K.; Lazrak, A.; Tsai, J.; Smith, O. M.; Dudakov, J.; Velardi, E.; van den Brink, M.
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Phase 2 study of selinexor in patients with myelodysplastic syndromes refractory to hypomethylating agents: Interim report
    Meeting Abstract

    Klimek, V. M.; Coleman, M.; Alvarez, K.; Sen, F.; Pichardo, J.; Kashyap, T.; Klebanov, B.
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Robust patient-derived xenografts (PDX) capture the disease fidelity of chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML)
    Meeting Abstract

    Balasis, M. E.; Yoshimi, A.; Vedder, A.; Feldman, K.; Ma, Y.; Zhang, H.; Lee, S. C. W.; Letson, C.; Niyongere, S.; Lu, S. X.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
    Journal Article

    Smyth, L. M.; Monson, K. R.; Jhaveri, K.; Drilon, A.; Li, B. T.; Abida, W.; Iyer, G.; Gerecitano, J. F.; Gounder, M.; Harding, J. J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • Ponatinib-induced ichthyosiform drug eruption: Insights into acquired ichthyosis
    Journal Article

    Xu, H.; Busam, K. J.; Mauro, M. J.; Markova, A.
    Dermatology Online Journal (2017)

    Fulltext@MSK | Save
  • Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12 372 individuals 10-49 years old: A population-based study from the National Health and Nutrition Examination Survey
    Journal Article

    Landgren, O.; Graubard, B. I.; Kumar, S.; Kyle, R. A.; Katzmann, J. A.; Murata, K.; Costello, R.; Dispenzieri, A.; Caporaso, N.; Mailankody, S.; more...
    Blood Cancer Journal (2017)

    Fulltext@MSK | Save
  • A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease
    Journal Article

    Mass, E.; Jacome-Galarza, C. E.; Blank, T.; Lazarov, T.; Durham, B. H.; Ozkaya, N.; Pastore, A.; Schwabenland, M.; Chung, Y. R.; Rosenblum, M. K.; more...
    Nature (2017)

    Fulltext@MSK | Save